{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atopic&page=2", "query": { "condition": "Atopic", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atopic&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T22:15:08.356Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04664153", "title": "Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Plaque Psoriasis" ], "interventions": [ { "name": "PF-07038124 ointment", "type": "DRUG" }, { "name": "Vehicle ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 104, "start_date": "2020-12-21", "completion_date": "2021-08-18", "has_results": true, "last_update_posted_date": "2022-08-26", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 15, "location_summary": "Fountain Valley, California • Cape Coral, Florida • Clearwater, Florida + 12 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Cape Coral", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Doral", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04664153" }, { "nct_id": "NCT07352566", "title": "Utilization of a Microdevice for Psoriasis and Atopic Dermatitis", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriasis", "Atopic Dermatitis" ], "interventions": [ { "name": "In situ cutaneous microdevice", "type": "DEVICE" }, { "name": "Triamcinolone", "type": "DRUG" }, { "name": "5-Fluorouracil", "type": "DRUG" }, { "name": "Calcipotriene", "type": "DRUG" }, { "name": "Tapinarof", "type": "DRUG" }, { "name": "Crisaborole", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Certolizumab", "type": "DRUG" }, { "name": "Infliximab", "type": "DRUG" }, { "name": "Secukinumab", "type": "DRUG" }, { "name": "Ixekizumab", "type": "DRUG" }, { "name": "Apremilast", "type": "DRUG" }, { "name": "Risankizumab", "type": "DRUG" }, { "name": "Ustekinumab", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Mycophenolate", "type": "DRUG" }, { "name": "Azathioprine", "type": "DRUG" }, { "name": "Chloroquine", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tofacitinib", "type": "DRUG" }, { "name": "Deucravacitinib", "type": "DRUG" }, { "name": "Dupilumab", "type": "DRUG" }, { "name": "Tralokinumab", "type": "DRUG" }, { "name": "Guselkumab", "type": "DRUG" }, { "name": "Tildrakizumab", "type": "DRUG" }, { "name": "Baractinib", "type": "DRUG" }, { "name": "Abrocitinib", "type": "DRUG" }, { "name": "Upadacitinib", "type": "DRUG" }, { "name": "Lebrikizumab", "type": "DRUG" }, { "name": "Nemolizumab", "type": "DRUG" }, { "name": "Ruxolitinib", "type": "DRUG" }, { "name": "Bimekizumab", "type": "DRUG" }, { "name": "Roflumilast", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2026-08-01", "completion_date": "2030-06-01", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07352566" }, { "nct_id": "NCT01177566", "title": "Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "pimecrolimus", "type": "DRUG" }, { "name": "topical medical device", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Emer, Jason, M.D.", "sponsor_class": "INDIV", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 20, "start_date": "2009-09", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2010-08-09", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01177566" }, { "nct_id": "NCT05200403", "title": "Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Crisaborole 2%", "type": "DRUG" }, { "name": "Vehicle treatment", "type": "DRUG" }, { "name": "Accelerometry device for children", "type": "DEVICE" }, { "name": "Accelerometry device for adult caregivers", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boston University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "75 Years", "sex": "ALL", "summary": "3 Months to 75 Years" }, "enrollment_count": 72, "start_date": "2022-07-26", "completion_date": "2024-02-15", "has_results": true, "last_update_posted_date": "2025-03-14", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05200403" }, { "nct_id": "NCT07277660", "title": "A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Galvokimig", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2025-12-29", "completion_date": "2028-03-06", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 20, "location_summary": "Oceanside, California • Santa Monica, California • Boca Raton, Florida + 15 more", "locations": [ { "city": "Oceanside", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07277660" }, { "nct_id": "NCT07003425", "title": "A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "APG777", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Apogee Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2025-05-14", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 22, "location_summary": "Fountain Valley, California • Los Angeles, California • Coral Gables, Florida + 19 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Margate", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07003425" }, { "nct_id": "NCT05084417", "title": "A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atopic Dermatitis", "Dermatology", "Vitiligo", "Alopecia Areata", "Hidradenitis Suppurativa", "Psoriasis" ], "interventions": [ { "name": "N/A This is an observational study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "OM1, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10000, "start_date": "2023-06-09", "completion_date": "2026-01-15", "has_results": false, "last_update_posted_date": "2023-11-01", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05084417" }, { "nct_id": "NCT03798561", "title": "Study to Evaluate ASN008 Topical Gel (TG)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dermatitis, Atopic", "Pruritus", "Dermatitis Eczema" ], "interventions": [ { "name": "ASN008 TG", "type": "DRUG" }, { "name": "Placebo TG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Asana BioSciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2019-01-14", "completion_date": "2020-03-20", "has_results": false, "last_update_posted_date": "2023-05-09", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 4, "location_summary": "Cortland, New York • High Point, North Carolina • San Antonio, Texas + 1 more", "locations": [ { "city": "Cortland", "state": "New York" }, { "city": "High Point", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" }, { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03798561" }, { "nct_id": "NCT05952986", "title": "A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "FB825 or Placebo in subcutaneous route", "type": "DRUG" }, { "name": "FB825 in intravenous route", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oneness Biotech Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 22, "start_date": "2023-05-03", "completion_date": "2024-03-26", "has_results": false, "last_update_posted_date": "2024-01-26", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05952986" }, { "nct_id": "NCT01257191", "title": "A Study to Compare the Effects of Different Sized Particles on Cells in the Nose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypersensitivity, Immediate", "Atopic Hypersensitivity" ], "interventions": [ { "name": "Carbon Black", "type": "DRUG" }, { "name": "Diesel Exhaust Particles", "type": "DRUG" }, { "name": "Fine Concentrated Ambient Particles", "type": "DRUG" }, { "name": "Ultrafine Concentrated Ambient Particles", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2010-04", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-06-10T22:15:08.356Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01257191" } ] }